Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage
- 1 December 2017
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 107, 63-72
Abstract
No abstract availableKeywords
Funding Information
- Ono Medical Research Foundation
- Nuffield Foundation
- University of Oxford
- Wellcome Trust
- Grant Foundation
- Tata Trusts
This publication has 42 references indexed in Scilit:
- Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for IndiaJournal of Public Health Policy, 2016
- Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?European Respiratory Journal, 2016
- Deep Whole-Genome Sequencing to Detect Mixed Infection of Mycobacterium tuberculosisPLOS ONE, 2016
- Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: A systematic reviewTuberculosis, 2016
- Clinical use of whole genome sequencing for Mycobacterium tuberculosisBMC Medicine, 2016
- Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistanceTuberculosis, 2016
- Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosisHealth Technology Assessment, 2015
- Drug-resistant tuberculosis: time for visionary political leadershipThe Lancet Infectious Diseases, 2013
- In Urban And Rural India, A Standardized Patient Study Showed Low Levels Of Provider Training And Huge Quality GapsHealth Affairs, 2012
- Whole-Genome Sequences of Two Clinical Isolates of Mycobacterium tuberculosis from Kerala, South IndiaJournal of Bacteriology, 2012